Follow
Heena khan
Heena khan
Senior Research Fellow at Chitkara University, Punjab
Verified email at chitkara.edu.in
Title
Cited by
Cited by
Year
Traumatic brain injury: mechanistic insight on pathophysiology and potential therapeutic targets
K Thapa, H Khan, TG Singh, A Kaur
Journal of Molecular Neuroscience 71 (9), 1725-1742, 2021
1372021
Poly (ADP-ribose) polymerase-1 as a promising drug target for neurodegenerative diseases
K Thapa, H Khan, U Sharma, AK Grewal, TG Singh
Life Sciences 267, 118975, 2021
592021
Pharmacological modulation of ubiquitin-proteasome pathways in oncogenic signaling
A Sharma, H Khan, TG Singh, AK Grewal, A Najda, ...
International Journal of Molecular Sciences 22 (21), 11971, 2021
452021
Sirtuin acetylation and deacetylation: a complex paradigm in neurodegenerative disease
H Khan, P Tiwari, A Kaur, TG Singh
Molecular Neurobiology 58, 3903-3917, 2021
432021
Therapeutic implications of cyclooxygenase (COX) inhibitors in ischemic injury
H Khan, K Sharma, A Kumar, A Kaur, TG Singh
Inflammation Research 71 (3), 277-292, 2022
392022
Therapeutic insights on ferroptosis in Parkinson's disease
K Thapa, H Khan, N Kanojia, TG Singh, A Kaur, G Kaur
European Journal of Pharmacology 930, 175133, 2022
372022
Neuropeptides: Potential neuroprotective agents in ischemic injury
P Saklani, H Khan, S Gupta, A Kaur, TG Singh
Life Sciences 288, 120186, 2022
362022
Mechanistic insight on the role of leukotriene receptors in ischemic–reperfusion injury
H Khan, A Gupta, TG Singh, A Kaur
Pharmacological Reports 73, 1240-1254, 2021
352021
Therapeutic modulation of the phosphatidylinositol 3-kinases (PI3K) pathway in cerebral ischemic injury
H Khan, A Singh, K Thapa, N Garg, AK Grewal, TG Singh
Brain Research 1761, 147399, 2021
352021
Pharmacological postconditioning: a molecular aspect in ischemic injury
H Khan, A Kashyap, A Kaur, TG Singh
Journal of Pharmacy and Pharmacology 72 (11), 1513-1527, 2020
322020
Novel targets explored in the treatment of alcohol withdrawal syndrome
A Gupta, H Khan, A Kaur, TG Singh
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2021
292021
α-Lipoic acid, an organosulfur biomolecule a novel therapeutic agent for neurodegenerative disorders: an mechanistic perspective
H Khan, TG Singh, RS Dahiya, MM Abdel-Daim
Neurochemical research 47 (7), 1853-1864, 2022
272022
Calpain inhibitors as potential therapeutic modulators in neurodegenerative diseases
H Khan, N Garg, TG Singh, A Kaur, K Thapa
Neurochemical Research 47 (5), 1125-1149, 2022
272022
Mechanistic insight on autophagy modulated molecular pathways in cerebral ischemic injury: from preclinical to clinical perspective
P Kalra, H Khan, A Kaur, TG Singh
Neurochemical Research, 1-19, 2022
242022
Intervention of neuroinflammation in the traumatic brain injury trajectory: In vivo and clinical approaches
NK Prabhakar, H Khan, AK Grewal, TG Singh
International Immunopharmacology 108, 108902, 2022
232022
Caspase-mediated regulation of the distinct signaling pathways and mechanisms in neuronal survival
H Khan, A Bangar, AK Grewal, P Bansal, TG Singh
International Immunopharmacology 110, 108951, 2022
212022
Pharmacological postconditioning by protocatechuic acid attenuates brain injury in ischemia–reperfusion (I/R) mice model: implications of nuclear factor erythroid-2-related …
H Khan, AK Grewal, TG Singh
Neuroscience 491, 23-31, 2022
202022
Vitamin D as therapeutic modulator in cerebrovascular diseases: a mechanistic perspectives
V Rihal, H Khan, A Kaur, TG Singh
Critical Reviews in Food Science and Nutrition 63 (25), 7772-7794, 2023
192023
Therapeutic and mechanistic intervention of vitamin D in neuropsychiatric disorders
V Rihal, A Kaur, TG Singh, MM Abdel-Daim
Psychiatry Research 317, 114782, 2022
172022
Therapeutic implications of sonic hedgehog pathway in metabolic disorders: Novel target for effective treatment
C Garg, A Kaur, TG Singh, VK Sharma, SK Singh
Pharmacological Research 179, 106194, 2022
162022
The system can't perform the operation now. Try again later.
Articles 1–20